Forbes contributor Bruce Japsen notes that the Cigna investment “fits the effort by health insurance companies to use claims data and related patient health information to better target illness and provide more cost-effective and high quality patient care. These efforts are also consistent with health insurer efforts to move away from fee-for-service medicine to value-based models that manage populations of patients, making sure healthcare is delivered in the right place, at the right time and in the right amount.” Read the full article here.